Future studies will be directed toward elucidation of molecular mechanisms underlying these neurodevelopmental disorders stemming from a reduction in bioactive, hypusinated eIF5A and the identification of downstream effectors of eIF5A. Here, EIF5A is linked to neurodevelopmental disorder.